Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$83.3M |
| 2 |
Bank of America
BAC
|
+$60.7M |
| 3 |
Wells Fargo
WFC
|
+$46.3M |
| 4 |
Citigroup
C
|
+$33.4M |
| 5 |
US Bancorp
USB
|
+$18.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$535M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$484M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$386M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$74.6M |
| 5 |
Biogen
BIIB
|
+$55.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 6.62% |
| 2 | Consumer Discretionary | 3.62% |
| 3 | Industrials | 2.16% |
| 4 | Materials | 1.56% |
| 5 | Technology | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
O-I Glass
OI
$1.08B
| – | – |
-32,952
| Closed | -$338K |
|
552
Oracle
ORCL
$423B
| – | – |
-111,155
| Closed | -$6.12M |
|
|
PARA
553
DELISTED
Paramount Global Class B
PARA
| – | – |
-945,703
| Closed | -$38.2M |
|
|
PCH
554
DELISTED
PotlatchDeltic
PCH
| – | – |
-6,333
| Closed | -$260K |
|
555
Progressive
PGR
$125B
| – | – |
-297,206
| Closed | -$23M |
|
556
Prologis
PLD
$133B
| – | – |
-7,102
| Closed | -$605K |
|
557
Phillips 66
PSX
$81.4B
| – | – |
-29,236
| Closed | -$2.99M |
|
558
Regeneron Pharmaceuticals
REGN
$80.8B
| – | – |
-61,705
| Closed | -$17.1M |
|
559
RTX Corp
RTX
$301B
| – | – |
-26,841
| Closed | -$2.31M |
|
560
SBA Communications
SBAC
$19.5B
| – | – |
-7,177
| Closed | -$1.73M |
|
561
Sally Beauty Holdings
SBH
$1.58B
| – | – |
-11,716
| Closed | -$174K |
|
562
SLB Ltd
SLB
$75B
| – | – |
-481,696
| Closed | -$16.5M |
|
563
Synopsys
SNPS
$79.7B
| – | – |
-3,381
| Closed | -$464K |
|
564
Simon Property Group
SPG
$72.3B
| – | – |
-164,059
| Closed | -$25.5M |
|
565
S&P Global
SPGI
$120B
| – | – |
-13,735
| Closed | -$3.37M |
|
566
Stanley Black & Decker
SWK
$15.7B
| – | – |
-10,453
| Closed | -$1.51M |
|
567
Bio-Techne
TECH
$11.3B
| – | – |
-8,440
| Closed | -$413K |
|
|
TPH
568
DELISTED
Tri Pointe Homes
TPH
| – | – |
-37,147
| Closed | -$559K |
|
569
TripAdvisor
TRIP
$1.26B
| – | – |
-82,306
| Closed | -$3.18M |
|
570
Tractor Supply
TSCO
$18.1B
| – | – |
-11,345
| Closed | -$205K |
|
571
Universal Health Services
UHS
$10.5B
| – | – |
-3,968
| Closed | -$590K |
|
572
Ulta Beauty
ULTA
$24.3B
| – | – |
-1,776
| Closed | -$445K |
|
573
UnitedHealth
UNH
$370B
| – | – |
-49,256
| Closed | -$10.7M |
|
574
Urban Outfitters
URBN
$6.59B
| – | – |
-594,197
| Closed | -$16.7M |
|
575
Visa
V
$677B
| – | – |
-23,455
| Closed | -$4.03M |
|
Similar funds
Ray Dalio's Q4 2019 Portfolio in Review
As of Q4 2019, Ray Dalio held 589 positions worth $9.79B, down 14% from $11.4B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Ray Dalio withdrew a net $2.32B in Q4 2019, closing 118 positions and reducing 104 holdings. Its most notable exit was Biogen, an estimated $55.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 6.6% of assets, up from 3.2% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Ray Dalio opened a new position in JPMorgan Chase worth $90.5M.
- Ray Dalio's largest Q4 2019 buy was JPMorgan Chase: 649,376 shares worth $90.5M.
- Ray Dalio added most to iShares MSCI Taiwan ETF in Q4 2019, an estimated $16.2M increase.
- Ray Dalio's biggest Q4 2019 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $535M.
- Ray Dalio fully exited Biogen in Q4 2019, selling an estimated $55.3M.
- Ray Dalio's ten largest holdings make up 67% of its $9.79B portfolio in Q4 2019.
- Ray Dalio opened 256 new positions and closed 118 in Q4 2019.
- Ray Dalio's portfolio value fell 14% quarter-over-quarter to $9.79B.
Based on Bridgewater Associates's 13F filing for Q4 2019, filed 13 Feb 2020.